Use of RP-TLC for determination of log P of isomeric chalcones and cyclic chalcone analogues

Journal of Planar Chromatography - Modern TLC

Volumn 19, Issue 108, 2006, Pages 124-128

  Rozmer, Zsuzsanna ^a   Perjési, Pál ^a   Takács Novák, Krisztina ^b  

^a UNIVERSITY OF PÉCS   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Chalcones; E 2 benzylidene 1 indanones; E 2 benzylidene 1 tetralones; Log P determination; RP TLC; Structure lipophilicity relationship

Indexed keywords

BIOCHEMISTRY; ESTERS; ISOMERS; METHANOL; SILICA GEL;

BIOLOGICALLY ACTIVE CHALCONE; CYCLIC CHALCONE; ETHYL ESTER; ISOMERIC CHALCONES; LIPOPHILICITY; METHANOL-WATER; SILANIZED SILICA GEL; STRUCTURE-LIPOPHILICITY RELATIONSHIP;

THIN LAYER CHROMATOGRAPHY;

CHALCONE DERIVATIVE; DIAZEPAM; METHANOL; PROGESTERONE; PROSTAGLANDIN E1; SILICA GEL; WATER;

ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG STRUCTURE; ISOMER; LIPOPHILICITY; PREDICTION; THIN LAYER CHROMATOGRAPHY; VALIDATION PROCESS;

EID: 33744964445     PISSN: 09334173     EISSN: None     Source Type: Journal    
DOI: 10.1556/JPC.19.2006.2.7     Document Type: Article

References (24)

1. M.S. Tute, Lipophilicity: A History. In: R. Mannhold, H. Kubinyi, and H. Timmerman (Eds), Methods and Principles in Medicinal Chemistry, Vol. 4, Lipophilicity in Drug Action and Toxicology (V. Pliska, B. Testa, and H. van de Waterbeemd, Eds). VCH, Weinheim, FRG, 1996, Chap. 2, pp. 7-26.
2. A. Leo, C. Hansch, and D. Elkins, Chem. Rev. 71 (1971) 525-616.
3. K. Takács-Novák, Acta Pharm. Hung. 67 (1997) 179-191.
4. A. Leo, Chem. Rev. 93 (1993) 1281-1306.
5. J.C. Dearden and G.M. Bresnen, Quant. Struct.-Act. Relat. 7 (1988) 133-144.
6. A. Avdeef J. Pharm. Sci. 82 (1993) 183-190.
7. W.J. Lambert, J. Chromatogr. A. 656 (1993) 469-484.
8. G.L. Biagi, M.C. Barbaro, A. Sapone, and M. Recanatini, J. Chromatogr. A. 662 (1994) 341-361.
9. A. Tsantili-Kakoulidou and A. Antoniadou-Vyza, J. Chromatogr. 445 (1998) 317-326.
10. A.D. Kossoy, D.S. Risley, and R.M Kleyle, Anal. Chem. 64 (1992) 1345-1349.
11. D. Matosiuk and K. Józwiak, J. Planar Chromatogr. 13 (2000) 52-56.
12. N.U. Perisic-Janjic, G.S. Uscumlic, and N.V. Valentic, J. Planar Chromatogr. 18 (2005) 92-97.
13. K. Mazák, J. Vámos, A. Nemes, A. Rácz, and B. Noszál, J. Chromatogr. A 996 (2003) 195-203.
14. K. Takács-Novák, P. Perjési, and J. Vámos, J. Planar Chromatogr. 14 (2001) 42-46.
15. P. Perjési, M. Takács, F. Osz, Z. Pintér, J. Vámos, and K. Takács-Novák, J. Chromatogr. Sci. 43 (2005) 289-295.
16. Chem3D Ultra 9.0.1., CambridgeSoft Corporation, Cambridge, MA, USA, 2005.
17. J.R. Dimmock, N.M. Kandepu, A.J. Nazarali, T.P. Kowalchuk, N. Motaganahalli, J.W. Quail, P. Mykytiuk, G.F. Audette, L. Prasad, P. Perjési, T.M. Allen, C.L. Santos, J. Szydlowski, E. De Chercq, and J. Balzarini, J. Med. Chem. 42 (1999) 1358-1366.
18. J.R. Dimmock, G.A. Zello, E.O. Oloo, J.W. Quail, H.-B. Kraatz, P. Perjési, F. Aradi, K. Takács-Novák, T.M. Allen, C.L. Santos, J. Balzarini, E. DeClerq, and J.P. Stables, J. Med. Chem. 45 (2002) 3103-3111.
19. P. Perjési, T. Nusser, Gy. Tarczay, and P. Sohár, J. Mol. Struct. 479 (1999) 13-19.
20. J. Almási K. Takács-Novák, J. Kökösi, and J. Vámos, Int. J. Pharm. 180 (1999) 13-22.
21. B. Testa, P.-A. Carrupt, P. Gaillard, and R.-S. Tsai, Intramolecular Interactions Encoded in Lipophilicity: Their Nature and Significance. In: R. Mannhold, H. Kubinyi, and H. Timmerman (Eds), Methods and Principles in Medicinal Chemistry, Vol. 4, Lipophilicity in Drug Action and Toxicology (V. Pliska, B. Testa, and H. van de Waterbeemd, Eds). VCH, Weinheim, FRG, 1996, Chap. 4, pp. 49-71.
22. B. Hallgas, Zs. Dobos, E. Osz, F. Hollósy, R.E. Schwab, E.Z. Szabó, D. Eros, M. Idei, Gy. Kéri, and T. Lóránd, J. Chromatogr. B 819 (2005) 283-291.
23. P. Perjési, A. Perjessy, E. Kolehmainen, F. Osz, M. Samalikova, and E. Virtanen, J. Mol Struct. 697 (2004) 41-47.
24. P. Perjési, J. Linnanto, F. Kolehmainen, E. Osz, and E. Virtanen, J. Mol. Struct. 740 (2005) 81-89.